Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study

被引：43

作者：

Montillo, M. ^{[1
]}

O'Brien, S. ^{[2
]}

Tedeschi, A. ^{[1
]}

Byrd, J. C. ^{[3
]}

Dearden, C. ^{[4
]}

Gill, D. ^{[5
]}

Brown, J. R. ^{[6
]}

Barrientos, J. C. ^{[7
]}

Mulligan, S. P. ^{[8
]}

Furman, R. R. ^{[9
]}

Cymbalista, F. ^{[10
]}

Plascencia, C. ^{[11
,12
]}

Chang, S. ^{[11
,12
]}

Hsu, E. ^{[11
,12
]}

James, D. F. ^{[11
,12
]}

Hillmen, P. ^{[13
]}

机构：

[1] Niguarda Canc Ctr, Milan, Italy

[2] MD Anderson Canc Ctr, Houston, TX USA

[3] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA

[4] Royal Marsden Hosp, London, England

[5] Princess Alexandra Hosp, Brisbane, Qld, Australia

[6] Dana Farber Canc Inst, Boston, MA 02115 USA

[7] Hofstra Northwell Sch Med, Hempstead, NY USA

[8] Royal North Shore Hosp, Sydney, NSW, Australia

[9] New York Presbyterian Hosp, Weill Cornell Med College, York, NY USA

[10] Hop Avicenne, Paris, France

[11] Pharmacyclics LLC, Sunnyvale, CA USA

[12] AbbVie Co, Sunnyvale, CA USA

[13] Leeds Teaching Hosp, St James Inst Oncol, Leeds, W Yorkshire, England

来源：

BLOOD CANCER JOURNAL | 2017年 / 7卷

关键词：

INHIBITION; DIAGNOSIS; CELL;

D O I：

10.1038/bcj.2017.5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：e524 / e524

页数：4

共 15 条

[1]

[Anonymous], 2014, BLOOD

[2] Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia [J].

Byrd, J. C. ;

Brown, J. R. ;

O'Brien, S. ;

Barrientos, J. C. ;

Kay, N. E. ;

Reddy, N. M. ;

Coutre, S. ;

Tam, C. S. ;

Mulligan, S. P. ;

Jaeger, U. ;

Devereux, S. ;

Barr, P. M. ;

Furman, R. R. ;

Kipps, T. J. ;

Cymbalista, F. ;

Pocock, C. ;

Thornton, P. ;

Caligaris-Cappio, F. ;

Robak, T. ;

Delgado, J. ;

Schuster, S. J. ;

Montillo, M. ;

Schuh, A. ;

de Vos, S. ;

Gill, D. ;

Bloor, A. ;

Dearden, C. ;

Moreno, C. ;

Jones, J. J. ;

Chu, A. D. ;

Fardis, M. ;

McGreivy, J. ;

Clow, F. ;

James, D. F. ;

Hillmen, P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (03) :213-223

[3] The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells [J].

Chang, Betty Y. ;

Huang, Min Mei ;

Francesco, Michelle ;

Chen, Jun ;

Sokolove, Jeremy ;

Magadala, Padmaja ;

Robinson, William H. ;

Buggy, Joseph J. .

ARTHRITIS RESEARCH & THERAPY, 2011, 13 (04)

[4] Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia - response to Rider etal [J].

Danilov, Alexey V. .

BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (02) :327-328

[5] Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis [J].

Di Paolo, Julie A. ;

Huang, Tao ;

Balazs, Mercedesz ;

Barbosa, James ;

Barck, Kai H. ;

Bravo, Brandon J. ;

Carano, Richard A. D. ;

Darrow, James ;

Davies, Douglas R. ;

DeForge, Laura E. ;

Diehl, Lauri ;

Ferrando, Ronald ;

Gallion, Steven L. ;

Giannetti, Anthony M. ;

Gribling, Peter ;

Hurez, Vincent ;

Hymowitz, Sarah G. ;

Jones, Randall ;

Kropf, Jeffrey E. ;

Lee, Wyne P. ;

Maciejewski, Patricia M. ;

Mitchell, Scott A. ;

Rong, Hong ;

Staker, Bart L. ;

Whitney, J. Andrew ;

Yeh, Sherry ;

Young, Wendy B. ;

Yu, Christine ;

Zhang, Juan ;

Reif, Karin ;

Currie, Kevin S. .

NATURE CHEMICAL BIOLOGY, 2011, 7 (01) :41-50

[6]

Ding Wei, 2007, Clin Adv Hematol Oncol, V5, P257

[7] Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes [J].

Dubovsky, Jason A. ;

Beckwith, Kyle A. ;

Natarajan, Gayathri ;

Woyach, Jennifer A. ;

Jaglowski, Samantha ;

Zhong, Yiming ;

Hessler, Joshua D. ;

Liu, Ta-Ming ;

Chang, Betty Y. ;

Larkin, Karilyn M. ;

Stefanovski, Matthew R. ;

Chappell, Danielle L. ;

Frissora, Frank W. ;

Smith, Lisa L. ;

Smucker, Kelly A. ;

Flynn, Joseph M. ;

Jones, Jeffrey A. ;

Andritsos, Leslie A. ;

Maddocks, Kami ;

Lehman, Amy M. ;

Furman, Richard ;

Sharman, Jeff ;

Mishra, Anjali ;

Caligiuri, Michael A. ;

Satoskar, Abhay R. ;

Buggy, Joseph J. ;

Muthusamy, Natarajan ;

Johnson, Amy J. ;

Byrd, John C. .

BLOOD, 2013, 122 (15) :2539-2549

[8] Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines [J].

Hallek, Michael ;

Cheson, Bruce D. ;

Catovsky, Daniel ;

Caligaris-Cappio, Federico ;

Dighiero, Guillaume ;

Doehner, Hartmut ;

Hillmen, Peter ;

Keating, Michael J. ;

Montserrat, Emili ;

Rai, Kanti R. ;

Kipps, Thomas J. .

BLOOD, 2008, 111 (12) :5446-5456

[9] AUTOIMMUNITY IN CHRONIC LYMPHOCYTIC-LEUKEMIA [J].

HAMBLIN, TJ ;

OSCIER, DG ;

YOUNG, BJ .

JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (07) :713-716

[10] Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment [J].

Hodgson, Kate ;

Ferrer, Gerardo ;

Pereira, Arturo ;

Moreno, Carol ;

Montserrat, Emili .

BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (01) :14-22

← 1 2 →